Compare Kyowa Kirin Co., Ltd. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
JPY 1,349,304 Million (Large Cap)
26.00
NA
0.04%
-0.28
4.32%
1.59
Revenue and Profits:
Net Sales:
147,375 Million
(Quarterly Results - Dec 2025)
Net Profit:
34,441 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
14.1%
0%
14.1%
6 Months
6.57%
0%
6.57%
1 Year
38.6%
0%
38.6%
2 Years
-2.44%
0%
-2.44%
3 Years
-4.04%
0%
-4.04%
4 Years
-8.01%
0%
-8.01%
5 Years
-10.49%
0%
-10.49%
Kyowa Kirin Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.99%
EBIT Growth (5y)
9.37%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.56
Tax Ratio
30.50%
Dividend Payout Ratio
51.30%
Pledged Shares
0
Institutional Holding
0.13%
ROCE (avg)
16.11%
ROE (avg)
7.78%
Valuation key factors
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
1.56
EV to EBIT
12.74
EV to EBITDA
9.81
EV to Capital Employed
1.75
EV to Sales
2.19
PEG Ratio
NA
Dividend Yield
0.04%
ROCE (Latest)
13.76%
ROE (Latest)
6.08%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 2 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
147,375.00
132,760.00
11.01%
Operating Profit (PBDIT) excl Other Income
48,660.00
26,966.00
80.45%
Interest
435.00
5,642.00
-92.29%
Exceptional Items
0.00
0.00
Consolidate Net Profit
34,441.00
3,969.00
767.75%
Operating Profit Margin (Excl OI)
280.00%
158.10%
12.19%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 11.01% vs -2.51% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 767.75% vs -85.64% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
496,826.00
495,558.00
0.26%
Operating Profit (PBDIT) excl Other Income
128,419.00
116,646.00
10.09%
Interest
3,644.00
709.00
413.96%
Exceptional Items
0.00
-15,135.00
100.00%
Consolidate Net Profit
67,040.00
59,870.00
11.98%
Operating Profit Margin (Excl OI)
205.90%
185.40%
2.05%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.26% vs 12.06% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 11.98% vs -26.26% in Dec 2024
About Kyowa Kirin Co., Ltd. 
Kyowa Kirin Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






